Medication info
Sardipin Tablet 5/160mg

Sardipin Tablet 5/160mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.94mg / 1 tabletValsartan›160mg / 1 tablet
Manufacturer / importer
Unimed Pharmaceutical Co., Ltd.
Appearance
Dark yellow oval film-coated tablet
Packaging
30 tablets (10 tablets/PTP packaging x 3)
Approval status
Active

MFDS item code 201601742 · Approved 2016.03.31 · Insurance code 649507200

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual ingredients (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual ingredients as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Unimed Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension that is not controlled by monotherapy with amlodipine or valsartan. It helps in effectively managing hypertension to reduce cardiovascular risk.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual ingredients (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual ingredients as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the active ingredient or similar compounds, as well as pregnant or breastfeeding women, patients with severe kidney or liver dysfunction, patients with certain heart conditions, should not take this medication. Patients with low sodium or body fluid levels should manage their condition before taking this medication, and during treatment, blood pressure and physical status should be closely monitored. Since this medication lowers blood pressure, if symptoms of hypotension occur, lie down and rest immediately, and seek medical assistance if necessary. Patients with high potassium levels or those taking other medications that can increase potassium levels should frequently monitor their potassium concentration and exercise caution. Patients with kidney issues or those who have received a kidney transplant should closely observe for changes in kidney function while on this medication. If symptoms of angioedema, such as swelling of the face, lips, or tongue occur during treatment, discontinue the medication immediately and consult healthcare professionals. Patients recovering from heart failure or myocardial infarction should closely monitor kidney function and blood pressure when taking this medication, as symptoms may worsen, and they should consult a healthcare professional. This medication has not been adequately studied for safety and efficacy in children, and is not recommended for those under 18 years of age. Elderly patients may take the same dosage as adults, but their conditions should be carefully monitored. Caution is needed while driving or operating machinery, as dizziness or fatigue may occur. This medication may interact with other drugs, so patients should inform healthcare professionals about any medications they are currently taking. Overdose may cause severe hypotension or cardiac-related side effects, so it is crucial to adhere strictly to the prescribed dosage and report any abnormal symptoms to healthcare professionals immediately.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, pruritus, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, pruritic edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, vesicular dermatitis, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, dysgeusia, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitability, sensory impairment, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. The recommended storage temperature is between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Dark yellow oval film-coated tablet

Package unit

30 tablets (10 tablets/PTP packaging x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.